EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieÄquivalenzstudieOpen Access · CC BY 4.0

Microfracture with or without collagen scaffold insertion for adults with chondral or osteochondral defects of the knee: the SISMIC RCT and its challenges during and after the COVID-19 pandemic

Michael R Whitehouse iD, Nicholas Howells iD, Lucy Dabner iD, Russell Thirard iD, Lucy Culliford iD, Elsa Marques iD, Petra Baji iD, Andrew Judge iD, Ashley W Blom iD, Amanda Burston iD, Catherine Jameson iD, Chris A Rogers iD

Health Technology Assessment · 2025

DOI: 10.3310/brts2415 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Health Technology Assessment, 2025. Verfasst von Michael R Whitehouse und 11 weiteren Autor:innen. Beteiligte Einrichtung: Musculoskeletal Research Unit, University of Bristol, Southmead Hospital, Bristol, UK. Hauptthemen laut MEDLINE: Arthroplasty, Subchondral, Collagen, Cartilage, Articular, COVID-19. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Technology Assessment programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Around 10,000 symptomatic knee articular cartilage injuries requiring repair occur annually in the United Kingdom, mostly in people under 35 years of age. Microfracture surgery aims to restore cartilage. Adding microstructural scaffolds made of collagen may further improve outcomes.

Objectives

To evaluate the clinical and cost-effectiveness of microstructural scaffold in patients undergoing microfracture for a symptomatic chondral or osteochondral defect of the knee.

Design

Multicentre, parallel two-group, superiority randomised controlled trial with blinding of participants, research staff and clinical care teams not involved in the surgery.

Setting

National Health Service hospitals offering arthroscopic chondral surgery.

Participants

Adults aged 18 years or older with symptomatic chondral or osteochondral defects of the knee on the medial or lateral femoral condyles, trochlea or patella and a chondral or osteochondral lesion measuring no more than 4 cm 2 . Exclusions were: unstable ligamentous injuries or meniscal tears that would not be treated; a knee with defects on the tibial chondral surface, < 50% native meniscal volume or requiring realignment surgery/osteotomy; and a lesion previously treated with microfracture.

Interventions

Lesions were debrided, and microfracture was performed on the exposed subchondral bone. Intervention: microfracture of the chondral or osteochondral lesion with insertion of a bilayer collagen matrix microstructural scaffold, fixed with stiches or fibrin glue. Comparator: microfracture alone. Postoperative physiotherapy was standardised. Participants were randomised 1 : 1 between intervention and control. Main outcome measures Primary outcome was the Knee Injury and Osteoarthritis Outcome Score at 24 months post randomisation. Secondary outcomes included International Knee Documentation Committee knee evaluation score; Tegner-Lysholm activity grading scale; EuroQol-5 Dimensions, five-level version; Work Productivity and Activity Impairment; complications and resource use measured at 3, 6, 12 and 24 months.

Results

Twenty-two patients were screened across 8 sites, 20 of whom were eligible on screening. Of the 20 patients considered initially eligible, 2 patients were not interested and 1 opted for chondroplasty; the remaining 17 all consented to participate. Between November 2021 and October 2022, 10 participants were randomised, 5 to microfracture and 5 to microfracture with scaffold. Three patients failed the final in-surgery eligibility check (lesions had healed), one decided not to have surgery and three were still waiting when the study was closed. The median age was 38 years, and four participants were female. Most participants (seven) had damage to the lateral femoral condyle, and six had a medial and/or lateral meniscal tear. All participants received the allocated treatment and are included in the reported results. When a scaffold was used, the surgery took on average 10 minutes longer. There were three serious adverse events, knee pain and swelling in one participant, and a suspected anaphylactic reaction in another.

Limitations

The SISMIC randomised controlled trial did not progress beyond the internal pilot phase due to insufficient recruitment. The target number of sites were opened, but recruitment was only 42% of the target 24 participants randomised. Insufficient data were collected to answer the research question.

Conclusions

The SISMIC randomised controlled trial was severely impacted by the COVID-19 pandemic, the limited resources available at sites and the reduced elective orthopaedic surgical activity. Future work To reflect contemporary practice, we recommend that a future trial evaluates three treatments: chondroplasty, chondroplasty with a microstructural scaffold and autologous chondrocyte implantation. Funding This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number NIHR127849.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthroplasty, SubchondralCollagenCartilage, ArticularCOVID-19Tissue ScaffoldsKnee InjuriesHumansFemaleAdultMaleUnited KingdomMiddle AgedCost-Benefit AnalysisKnee JointTechnology Assessment, Biomedical

Stichwörter der Autor:innen

CHONDRAL KNEE DEFECTSCOLLAGEN MATRIX SCAFFOLDKNEE SURGERYMICROFRACTUREOSTEOCHONDRAL KNEE DEFECTSRANDOMISED CONTROLLED TRIAL

Substanzen

Collagen

Autor:innen und Institutionen

  • Musculoskeletal Research Unit, University of Bristol, Southmead Hospital, Bristol, UK.
  • The NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol, Bristol, UK.
  • Avon Orthopaedic Centre, Neuroscience and Musculoskeletal Division, North Bristol NHS Trust, Southmead Hospital, Bristol, UK.
  • Bristol Trials Centre, Bristol Medical School, University of Bristol, Bristol, UK.
  • Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, UK.

ORCID-Profile: Michael R Whitehouse, Nicholas Howells, Lucy Dabner, Russell Thirard, Lucy Culliford, Elsa Marques, Petra Baji, Andrew Judge, Ashley W Blom, Amanda Burston, Catherine Jameson, Chris A Rogers

Förderung

  • Health Technology Assessment programme

Zitieren

APA

Whitehouse, M. R., Howells, N., Dabner, L., Thirard, R., Culliford, L., Marques, E., Baji, P., Judge, A., Blom, A. W., Burston, A., Jameson, C., & Rogers, C. A. (2025). Microfracture with or without collagen scaffold insertion for adults with chondral or osteochondral defects of the knee: the SISMIC RCT and its challenges during and after the COVID-19 pandemic. Health Technology Assessment. https://doi.org/10.3310/brts2415

Vancouver

Whitehouse MR, Howells N, Dabner L, Thirard R, Culliford L, Marques E, et al. Microfracture with or without collagen scaffold insertion for adults with chondral or osteochondral defects of the knee: the SISMIC RCT and its challenges during and after the COVID-19 pandemic. Health Technology Assessment. 2025. doi:10.3310/brts2415

BibTeX
@article{Whitehouse2025,
  author = {Whitehouse, Michael R and Howells, Nicholas and Dabner, Lucy and Thirard, Russell and Culliford, Lucy and Marques, Elsa and Baji, Petra and Judge, Andrew and Blom, Ashley W and Burston, Amanda and Jameson, Catherine and Rogers, Chris A},
  title = {Microfracture with or without collagen scaffold insertion for adults with chondral or osteochondral defects of the knee: the SISMIC RCT and its challenges during and after the COVID-19 pandemic},
  journal = {Health Technology Assessment},
  year = {2025},
  doi = {10.3310/brts2415}
}
Kostenlos starten →